Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Ruxience [legacy through FY23] by Quarter
Ruxience (rituximab biosimilar) [legacy through FY23] — International operational (constant-currency) YoY (%) (%)
Pfizer Ruxience [legacy through FY23]: 46.0% in Q4 2023, down 13.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the Q4 2023 figure comes from
“|| Ruxience | 88 | 101 | (13%) | (12%) | 62 | 83 | (25%) | 26 | 18 | 43% | 46%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
Reported in Form 8-K Revenue Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Ruxience (rituximab biosimilar) [legacy through FY23] — International operational (constant-currency) YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q4 2023 | Dec 31, 2023 | 46.0% | -13.0 pts | Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗ |
| Q3 2023 | Oct 1, 2023 | 35.0% | -3.0 pts | Form 8-K (Earnings / Guidance Release) (pfe-10012023xex99.htm, filed 2023-10-31) ↗ |
| Q2 2023 | Jul 2, 2023 | 51.0% | -17.0 pts | Form 8-K (Earnings / Guidance Release) (pfe-07022023xex99.htm, filed 2023-08-01) ↗ |
| Q4 2022 | Dec 31, 2022 | 59.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗ |
| Q3 2022 | Oct 2, 2022 | 38.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-10022022xex99.htm, filed 2022-11-01) ↗ |
| Q2 2022 | Jul 3, 2022 | 68.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-07032022xex99.htm, filed 2022-07-28) ↗ |
| Q1 2022 | Apr 3, 2022 | 23.0% | – | Form 8-K (Earnings / Guidance Release) (pfe-04032022xex99.htm, filed 2022-05-03) ↗ |
Cite this data
StockData. (2026). Pfizer Ruxience [legacy through FY23] (%), quarterly Q1 2022–Q4 2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/ruxience-leg-oper-intl
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.